Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Organigram Holdings Inc (OGI.TO)

Organigram Holdings Inc (OGI.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 372,988
  • Shares Outstanding, K 163,591
  • Annual Sales, $ 80,413 K
  • Annual Income, $ -9,542 K
  • 60-Month Beta 1.58
  • Price/Sales 3.77
  • Price/Cash Flow N/A
  • Price/Book 1.13

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 02/29/20
See More
  • Average Estimate -0.01
  • Number of Estimates 3
  • High Estimate 0.00
  • Low Estimate -0.01
  • Prior Year -0.05
  • Growth Rate Est. (year over year) +80.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.95 +27.69%
on 03/12/20
3.05 -18.36%
on 03/30/20
-0.15 (-5.68%)
since 03/06/20
3-Month
1.95 +27.69%
on 03/12/20
4.74 -47.47%
on 01/16/20
-0.31 (-11.07%)
since 01/06/20
52-Week
1.95 +27.69%
on 03/12/20
11.30 -77.96%
on 05/21/19
-7.15 (-74.17%)
since 04/05/19

Most Recent Stories

More News
Organigram Receives Health Canada License Renewal and Expansion for Final Elements of Phase 5 and Provides COVID-19 Update

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce that the Company...

OGI : 1.7200 (+6.17%)
OGI.TO : 2.45 (+7.46%)
Ideal Potency of Edible Products 5MGs of THC or Less, Organigram Consumer Research Survey Concludes

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, has released summary findings gathered...

OGI : 1.7200 (+6.17%)
OGI.TO : 2.45 (+7.46%)
Organigram Expands Leadership Team with the Appointment of Chief Strategy Officer and Newly Appointed Chief Financial Officer

--Derrick West, currently on Board of Directors, joins as Chief Financial Officer

OGI : 1.7200 (+6.17%)
OGI.TO : 2.45 (+7.46%)
Organigram Holdings Inc. Announces Election of Directors

Organigram Holdings Inc. ("Organigram" or the "Corporation") (TSX: OGI) (NASDAQ: OGI) announced today that each of the eight nominees listed in its management information circular dated January 23, 2020...

OGI.TO : 2.45 (+7.46%)
OGI : 1.7200 (+6.17%)
Organigram Continues Cannabis 2.0 Roll Out, Releases Edison Vape Pens Powered by Feather, and Edison Bytes to Markets Across Canada

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to continue the roll out of...

OGI : 1.7200 (+6.17%)
OGI.TO : 2.45 (+7.46%)
How CBD Nanoemulsion Could Highly Optimize Quickly Growing CBD-Infused Products

(MENAFN - Financial News Media) Palm Beach, FL -January 30, 2020 - A decade ago, almost nobody had heard of CBD aside from a handful of researchers. Today it's a different story. The expanding CBD market...

PBIO : 2.0000 (-2.44%)
ACB : 0.8181 (+1.05%)
ACB.TO : 1.16 (+2.65%)
OGI : 1.7200 (+6.17%)
OGI.TO : 2.45 (+7.46%)
CRON : 5.73 (+3.80%)
CRON.TO : 8.23 (+4.97%)
BOSS.CN : 0.210 (unch)
BOSQF : 0.1483 (-1.13%)
How CBD Nanoemulsion Could Highly Optimize Quickly Growing CBD-Infused Products

A decade ago, almost nobody had heard of CBD aside from a handful of researchers. Today it's a different story. The expanding CBD market is estimated to grow at an explosive rate - from $5 billion in 2019...

PBIO : 2.0000 (-2.44%)
ACB : 0.8181 (+1.05%)
ACB.TO : 1.16 (+2.65%)
OGI : 1.7200 (+6.17%)
OGI.TO : 2.45 (+7.46%)
CRON : 5.73 (+3.80%)
CRON.TO : 8.23 (+4.97%)
BOSS.CN : 0.210 (unch)
BOSQF : 0.1483 (-1.13%)
Edison La Strada Selected Favourite THC Flower in Canada

--Company receives four awards and five acknowledgments, including Top Pre-Roll (Edison El Dorado), Top THC Oil (Edison Sativa) and Top CBD Oil (Edison CBD)

OGI : 1.7200 (+6.17%)
OGI.TO : 2.45 (+7.46%)
Organigram Secures Supply Agreement With Medical Cannabis by Shoppers

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce it has secured...

OGI : 1.7200 (+6.17%)
OGI.TO : 2.45 (+7.46%)
Organigram Reports First Quarter Fiscal 2020 Results

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce its results for...

OGI : 1.7200 (+6.17%)
OGI.TO : 2.45 (+7.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

2nd Resistance Point 2.71
1st Resistance Point 2.49
Last Price 2.45
1st Support Level 2.16
2nd Support Level 2.05

See More

52-Week High 11.30
Fibonacci 61.8% 7.73
Fibonacci 50% 6.63
Fibonacci 38.2% 5.52
Last Price 2.45
52-Week Low 1.95

See More

Business Summary

OrganiGram Holdings Inc is a Canada licensed producer of cannabis products. The company focuses on producing indoor-growth cannabis for patients and adult recreational consumers, as well as developing overseas business partnerships.

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar